Akari Therapeutics Plc - American Depositary Shares (AKTX) SEC filings
AKTX SEC filings moved a median of 0.00% by the close. AKTX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the AKTX overview →
19 measured AKTX SEC filing events.
Where these AKTX SEC filings landedvs 19 measured AKTX SEC filing reactions
| Middle 50% of AKTX SEC filing reactions | -5.32% to +2.86% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 AKTX SEC filing events with a measured close landed between -5.32% and +2.86%; 47% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger | Press release | — | -4.82% | |
| Form 8-K Akari Therapeutics Plc For: May 16 | SEC filing · Form 8-K | +0.00% | +2.78% | |
| Form 10-Q Akari Therapeutics Plc For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +2.78% | |
| Form 8-K Akari Therapeutics Plc For: May 01 | SEC filing · Form 8-K | +9.49% | +5.84% | |
| Form 8-K Akari Therapeutics Plc For: Apr 25 | SEC filing · Form 8-K | +5.03% | -13.02% | |
| Form 8-K Akari Therapeutics Plc For: Apr 05 | SEC filing · Form 8-K | — | -14.06% | |
| Form 8-K Akari Therapeutics Plc For: Apr 01 | SEC filing · Form 8-K | +0.00% | -18.38% | |
| Form 10-K Akari Therapeutics Plc For: Dec 31 | SEC filing · Form 10-K | +0.00% | -18.38% | |
| Form 8-K Akari Therapeutics Plc For: Mar 11 | SEC filing · Form 8-K | +0.01% | -0.47% | |
| Form 8-K Akari Therapeutics Plc For: Mar 04 | SEC filing · Form 8-K | +0.00% | -5.83% | |
| Form D Akari Therapeutics Plc | SEC filing · Form D | — | -1.02% | |
| Form 8-K Akari Therapeutics Plc For: Dec 27 | SEC filing · Form 8-K | — | +2.41% | |
| Form 6-K Akari Therapeutics Plc For: Dec 01 | SEC filing · Form 6-K | +6.18% | +10.24% | |
| Form 6-K Akari Therapeutics Plc For: Nov 16 | SEC filing · Form 6-K | -8.91% | -2.42% | |
| Form EFFECT Akari Therapeutics Plc | SEC filing · Form EFFECT | — | +2.27% | |
| Form EFFECT Akari Therapeutics Plc | SEC filing · Form EFFECT | — | +2.94% | |
| Form F-3 Akari Therapeutics Plc | SEC filing · Form F-3 | +0.00% | +3.31% | |
| Form POS AM Akari Therapeutics Plc | SEC filing · Form POS | +0.00% | +3.31% | |
| Form D Akari Therapeutics Plc | SEC filing · Form D | +0.00% | +0.00% |
Keep exploring
More AKTX: earnings → · analyst actions → · AKTX overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BioLineRx Ltd. - American Depositary Shares (BLRX) | 148 | -0.82% | 40% |
| INMED PHARMACEUTICALS (IMLFF) | 148 | 0.00% | 48% |
| BeyondSpring, Inc. - Ordinary Shares (BYSI) | 146 | 0.00% | 49% |
| Clearside Biomedical, Inc. (CLSD) | 145 | 0.00% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.